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ABSTRACT 
Metabolic  network  provides  a  unified  platform  to 
integrate  all  the  biological  information  on  genes, 
proteins, metabolites, drugs and drug targets for a 
comprehensive system level study of the relationship 
between  metabolism  and  disease.  In  recent  times, 
drug-target  identification  by  in  silico  methods  has 
emerged causing a phenomenal achievement in the 
field  of  drug  discovery.  This  paper  focuses  on 
describing how microbial drug target identification 
can  be  carried  out  using  bioinformatic  tools. 
Specifically, it highlights the use of metabolic ‘choke 
point’  and  ‘load  point’  analyses  to  understand  the 
local and global properties of metabolic networks in 
Pseudomonas  aeruginosa  and  allow  us  to  identify 
potential drug targets. We also list out top 10 choke 
point enzymes based on the load point values and the 
number of shortest paths. A non-pathogenic bacterial 
strain  Pseudomonas  putida  KT2440  and  a  related 
pathogenic bacteria P.aeruginosa PA01 was selected 
for the network anlaysis. A comparative study of the 
metabolic networks of these two microbes highlights 
the  analogies  and  differences  between  their 
respective  pathways.  System  analysis  of  metabolic 
networks will help us in identifying new drug targets 
which  in  turn  will  generate  more  in-depth 
understanding of the mechanism of diseases and thus 
provide better guidance for drug discovery.   
1. INTRODUCTION 
Metabolic  pathways  are  a  central  paradigm  in 
biology. The metabolic network is of special interest 
among  the  different  types  of  biological  networks 
because  it  can  integrate  the  experimental  data  for 
different  types  of  molecules  (transcriptomics  for 
genes, proteomics for enzymes and metabolomics for 
metabolites). Moreover metabolites are more closely 
related  to  the  phenotype  of  an  organism  and  the 
health and disease states of human can be described 
more meaningfully by the metabolic state of human 
cells,  tissues,  organs  and  the  organism  as  a  whole. 
Thus  network-based  pathways  are  emerging  as  an 
important  paradigm  for  analysis  of  biological 
systems.  Despite  the  advent  of  the  high-throughput 
techniques  sparked  by  the  genomics  revolution, 
discovery  and  development  of  new  antibiotics  has 
lagged in recent years due to the serious problem of 
evolution of antibiotic resistance [1]. 
Comparative  genomics  has  provided  a  gradual 
increase  in  large-molecule  targets.  It  has  actually 
created the new problem of how to select potential 
drug targets from a larger pool [2]. Putative targets 
must be essential for the survival of the pathogen and 
enzymes that do not have human homologs may also 
be attractive drug targets [3]. Among the numerous 
criteria  used  in  the  selection  of  antimicrobial 
compounds, certain criteria are clearly influenced by 
the  choice  of  target.  These  include  breadth  of 
spectrum,      selectivity  of  the  agent  for  microbial 
systems and frequency of resistance. 
Anti-microbial  targets  can  now  be  identified  and 
evaluated  by  automatically  comparing  all  relevant 
pathogen  genomes  and  the  human  host  genome. 
Genes that are conserved across different pathogens 
represent attractive target candidates for new broad-
spectrum  antibiotics  [4].  Antibiotic  resistance  has 
increased over the past two decades and has reduced 
the usefulness of effective antibiotics.  
Pseudomonas aeruginosa is a major life-threatening 
opportunistic  pathogen  that  commonly  infects 
immunocompromised  patients.  The  organism  is 
inherently resistant to many drug classes and is able 
to  acquire  resistance  to  all  effective  antimicrobial 
drugs and has the ability to adapt and thrive in many 
ecological niches, including humans [5]. Besides P. 
aeruginosa continues to be a major pathogen among 
patients  with  immuno-suppression,  cystic  fibrosis, 
malignancy,  and  trauma  [6].  A  thorough 
understanding of the metabolism of P. aeruginosa is 
thus  pivotal for the design of effective intervention 
strategies.  On  the  other  hand,  Pseudomonas  putida 
KT2440  is  a  metabolically  versatile  and  non-
pathogenic saprophytic soil bacterium that has been 
certified as a biosafety host for the cloning of foreign 
genes.  Although  there  is  a  high  level  of  genome 
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conservation  (85%)  with  the  pathogenic 
P.aeruginosa,  key  virulence  factors  including 
exotoxin A and type III secretion systems are absent 
in P.putida. The non-pathogenic nature of P. putida 
has been used potentially in agriculture, biocatalysis 
and bioremediation [7].  
Prioritizing  targets  will  therefore  be  an  essential 
process  in  industrial  drug  discovery.  Targets  have 
become plentiful, yet new antimicrobial agents have 
been slow to emerge from this effort. A prerequisite 
for mapping metabolic pathways on genomic data is 
the annotation of proteins with metabolic information. 
These  metabolic  pathways  are  functional  units  of 
metabolic  networks  and  help  us  in  understanding a 
detailed analysis of network robustness and complex 
reaction  networks.  The  commonly  known  Enzyme 
Commission  (EC)  numbers  have  been  given  to 
characterized  proteins  in  order  to  classify  the 
enzymatic chemical reactions of proteins.  
Graph  theory  based  pathway  analysis  will  be  very 
useful in analyzing metabolic networks consisting of 
reactions,  metabolites  and  enzymes  [8].  Metabolic 
networks  can  be  represented  as  a  metabolite  graph 
consisting  of  nodes  (metabolites)  and  edges 
(reactions)  with  large  number  of  connecting  links. 
Such  representation  of  network  allows  the 
characterization  of  the  metabolic  pathways  with 
respect to degree of metabolite (nodes) connectivity 
defined  as  possible  number  of  reactions  by  a 
metabolite;  and  the  degree  of  interconnectivity  or 
average  network  diameter  defined  as  the  average 
shortest path length [9]. 
In our previous study, a differential genome analysis 
of  metabolic  enzymes  in  Pseudomonas  aeruginosa 
for  drug  target  identification  was  performed  and 
identified  potential  drug  targets  in  unique  and 
common  pathways  [10].  In  the  present  work,  we 
extend our analysis to the identification of potential 
drug targets based on the concept of ‘load points’ and 
‘choke points’. This approach enables to understand 
the  local  and  global  properties  of  the  metabolic 
network thereby allowing us to identify potential drug 
targets in the pathogenic bacterium. 
Using  the  current  knowledge  about  proteins,  an 
accurate  prediction  of  protein  druggability  can 
capitalize on the huge investments already made in 
structural  genomics  initiatives  by  identifying  highly 
druggable  proteins  and  thereby  leading  to  target 
identification  and  validation.  While  our  current 
knowledge may be limited the ability to assess protein 
druggability in a fast and reliable manner is simply 
one  of  many  tools  that  can  help  to  streamline  and 
enhance this process, especially when integrated with 
other computational and experimental approaches to 
target identification and validation.  
2. METHODOLOGY 
2.1. Load Point and Choke Point analyses 
‘Load point’ of a metabolite in a metabolic network is 
defined  as  the  ratio  of  number  of  k-shortest  paths 
passing  through  the  metabolite  (enzyme)  and  its 
nearest neighbour links [11]. These load point values 
give a global view of the metabolic network and help 
in  the  anlaysis  of  the  metabolic  pathway  reactions. 
Pathways that are highly connected in the metabolism 
of the cell tend to have high load values. Moreover 
the lethality of a metabolite/enzyme depends on the 
number of connections it has in the whole metabolic 
network  [12].  Enzymes  with  large  number  of 
connections  are  found  to  be  three  times  more 
essential  than  the  proteins  that  interact  with  only a 
few other neighbors.              
On the other hand, ‘choke point’ enzymes are those 
taking  part  in  a  reaction  that  consumes  unique 
specific metabolite (substrate) or uniquely produces 
specific  metabolite  (product)  in  the  metabolic 
network [13]. These choke point enzymes are crucial 
points in the metabolic pathway and inactivation of 
these important enzymes may lead to the disruption of 
the metabolic network of the bacterium.     
2.2. Identification of Potential Drug Targets  
To  identify  potential  drug  targets,  chokepoint  and 
load point analyses was carried out in the metabolic 
network  of  P.aeruginosa  PAO1.  The  complete 
genome sequence of P.aeruginosa PAO1 and Homo 
sapiens  is  available  [5,  14].  Metabolic  pathway 
information was obtained from Kyoto Encyclopedia 
of Genes and Genomes (KEGG) [15]. In our previous 
study [10], we listed out a total of 361 enzymes as 
potential drug targets by differential genome analysis 
between  the  pathogen  P.aeruginosa  and  the  host 
H.sapiens  by  subjecting  to  BLAST  [16]  search 
against  human  protein  sequence  database  at  an  E-
value  cutoff  of  10
-2.  Here we extend our study to 
choke point and load point analysis using the Pathway 
Hunter Tool (PHT) [17] to identify enzymes that are 
essential for the bacterial network. 
Using  the  above  tool  we  calculated  shortest  path 
distribution,  the  average  path  length  and  average 
alternate  paths  in  the  P.aeruginosa  metabolic 
network.  The  important  aspects of global similarity 
and  local  similarity  need  to  be  considered  while 
performing  choke  point  analysis  since  higher  the 
similarities smaller will be the network diameter and 
the  average degree of nodes [17]. In this study we 
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chose the local similarity score as 20% and the global 
similarity  score  as  10%. We then identified top 10 
choke point enzymes based on the number of shortest 
paths  using  the  tool.  A  comparative  study  was 
performed  between  the  pathogen  choke  point 
enzymes  with  the  human  metabolic  network  to 
differentiate  human  choke  points  with  that  of  the 
bacterial choke points. Finally for the predicted list of 
choke  points  in  the  pathogen  we  performed  a 
homology  search  against  the  human  genome  using 
BLAST. 
We also carried out a comparative study of metabolic 
pathways based on shortest path analysis between the 
pathogenic  bacterium  P.aeruginosa  and  non-
pathogenic  P.putida  to  highlight  the  analogies  and 
differences  between  their  respective  pathways.  We 
calculated the shortest path distribution, the average 
path length and average alternate paths.  
3. RESULTS AND DISCUSSION 
Network  models  are  crucial  for  shaping  our 
understanding  of  complex  networks  and  help  to 
explain  the  origin  of  observed  network 
characteristics. Based on the network characteristics, 
metabolite information can be used to calculate the k-
shortest  paths  between  metabolites  (substrate  and 
product).  Distance  in  metabolic  networks  can  be 
measured  in terms of path length, which represents 
the number of links passing between two nodes. As 
there are many alternative paths between two nodes, 
the  shortest  path  with  the  smallest number of links 
between  the  selected  nodes  has  a  special  property. 
The average path length represents the mean over the 
shortest paths between all pairs of nodes in the entire 
network of the bacterium [9]. 
3.1. Metabolic Network Topology of P.aeruginosa 
and P.putida 
A comparative study of metabolic pathways based on 
shortest  path  analysis  was  carried  out  between 
P.aeruginosa and P.putida. Analysis of the metabolic 
network is based on shortest path length since large 
numbers of biochemical reactions follow shortest path 
rather than longer paths. The metabolic network for 
P.aeruginosa  used  in  this  study  included  996 
reactions  and  1063  metabolites  with  network 
diameter  of  33  and  the  average  degree  distribution 
(Connectivity) of 3.09 whereas metabolic network of 
P.putida includes 992 reactions and 1087 metbolites 
with network diameter of 31 and the average degree 
distribution of 3.0  
P.aeruginosa  and  P.Putida  have  more  or  less  the 
same network diameter and the same average degree 
distribuiton  of  ~3.0  (average  connectivity)  and 
approximately  the  same  number  of  reactions.  The 
average  path  lengths  (shortest  path/k-shortest  path) 
for the P.aeruginosa and P.Putida are 8.69/9.06 and 
8.43/8.79 respectively.The shortest path distribution 
for  P.aeruginosa  and  P.Putida  is  shown  below  in 
Figure 1. 
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Figure  1.  Graph  showing  the  shortest  path 
distribution  in  P.aeruginosa  PA01  and  P.Putida 
KT2440. 
Few nodes with a very large number of connectivity 
links  are  termed  as  hubs  as  they  hold  many  nodes 
together.  However,  even  the  complete  removal  of 
nodes that act as hubs that are highly linked in the 
network  can  be  adjusted  through  redundancy  or 
alternate  pathways  that  maintain  the  usual  flow  of 
metabolites in the cell. Within a model of a highly 
interconnected  network:  if  one  part  of  a  web  is 
perturbed,  other  compensatory  changes  in  flow  are 
likely to occur as well, analogous to a ripple effect 
spreading through the network.  
Alternate  pathway  lengths  can  thus  be  used  to 
characterize  the  large-scale  properties  of  metabolic 
networks.  A  contrast  in  the  topological  behaviour 
between the selected model organisms is seen where a 
shift  in  the  average  alternate  path  in  both  the 
organism  is  observed.  P.aeruginosa  has  a  greater 
number  of  alternate  paths  between  path  lengths  19 
and 28 whereas P.Putida has more alternate paths at 
path  lengths  between  12  and  18  (Figure  2).  This 
difference in the average alternate path between the 
two  microbes  may  imply  biological  significance 
which can be explored through the network analysis.  
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Figure  2.  Average  alternate  path  distribution  in 
P.aeruginosa and P.Putida. 
It is important to keep track of alternate paths in the 
metabolic network which is an indicator of the ability 
of the pathogen to survive under extreme conditions. 
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Most of the enzymes can be replaced by alternative 
reactions  that  utilize  the  same  substrate  or produce 
the  specific  product,  thereby  allowing  a  given 
pathway to operate [18].  Hence blocking a path may 
not be vital as pathogens can make use of an alternate 
path performing similar functions. We further carried 
out  ‘load  point’  analysis  for  the  two  microbes  and 
identified top 10 metabolite load points in them. The 
loads  on  the  metabolites  differ  between  the  two 
bacterial networks (Table 1 and Table 2).  
 
   M etab olites R ank   R ank    L oad    L oad   L ink s  Link s  k-shortest p athk-sh ortest path  
in pae in  ppu (in) p ae (in ) ppu(in) pae(in) ppu (in) pae (in ) ppu
4-Fum arylacetoacetate 1 1 2.4963 2.59503 1 1 11822 11593
4-M aley lacetoacetate 2 2 2.4591 2.55418 1 1 11390 11129
H om ogentisate 3 3 2.4422 2.53082 1 1 11200 10872
G TP 4 5 2.3215 2.17462 1 1 9926 7614
D -R ibulose 5-ph osphate 5 8 2.2981 2.01551 2 3 19393 19482
3-Phospho-D -glycero yl phosph ate 6 6 2.2072 2.16432 2 2 17709 15072
O -Ph ospho-L -serine 7 7 2.1005 2.03306 1 1 7958 6609
2-Phospho-D -glycerate 8 9 1.9808 1.98454 2 2 14121 12592
D ephosph o-C oA 9 4 1.9044 2.21238 2 2 13082 15814
C TP 10 15 1.8358 1.74179 2 2 12215 9878
D -X ylulose 5-phosphate 14 10 1.7219 1.94826 4 3 21800 18215  
Table 1. Top 10 Metabolite load points based on 
incoming load value in P.aeruginosa (pae) and P. 
putida (ppu).  
 
  M etab olite R an k  R an k   L oa d  Lo a d  L in k s  L in ks  k-sh ortest p ath k-sh o rtest p ath  
in  pae in pp u  (o ut) p ae(ou t) ppu (o u t) p ae(ou t) ppu (o ut) p ae (ou t) ppu
4-M aley lacetoacetate 1 1 2.49 62 8 2.595 03 1 1 1 1822 1 1593
3-Pho sp ho-D -glycero y l pho sph ate 2 2 2.22 45 4 2.1889 2 2 1 8018 1 5447
gam m a-L-G lu tam y l-L -cy stein e 3 8 2.20 84 3 1.938 55 1 1 88 65 60 13
2-Pho sp ho-D -glycerate 4 4 2.015 9 2.019 89 2 2 1 4625 1 3045
U D P 5 9 1.94 65 8 1.930 33 4 4 2 7291 2 3855
D -R ibulose 5-ph o sphate 6 3 1.90 18 6 2.025 57 3 3 1 9573 1 9679
4-Fum arylacetoa cetate 7 7 1.83 90 2 1.941 13 2 2 1 2254 1 2057
U D P -N -acety lm uram oy l-L -alan y l-D -g am m a-
gluta m y l-m eso-2 ,6-d iam in op im e late
H o m ogentisate 9 10 1.78 67 6 1.879 38 2 2 1 1630 1 1335
3-Pho sp ho-D -glycerate 10 14 1.75 14 5 1.769 15 4 4 2 2453 2 0304
D -X y lulo se 5-ph osphate 11 6 1.73 36 5 1.9646 4 3 2 2057 1 8515
1 1 61 08 62 51 8 5 1.83 59 2 1.977 37
 
Table 2. Top 10 Metabolite load points based on 
outgoing load value in P.aeruginosa (pae) and P. 
putida (ppu). 
Although  the  degree  of  metabolites  and  its  load  in 
both the organisms are more or less similar but they 
differ based on the load points. From the above point 
of view ‘load points’ provide a more global measure 
of  metabolic  activity  than  the  local  connectivity 
analysis. The difference in the load values between 
the  above  two  organisms  suggest  the  need  for 
deciphering  the  metabolic  network  topology  in  a 
more significant manner.      
3.2. Top 10 choke point enzymes in Pseudomonas 
aeruginosa  
Choke point analysis was carried out for the whole 
metabolic  network  using  the  Pathway  Hunter  Tool. 
We  had  reported  a  total  of  361  enzymes  in  both 
unique  and  common  pathways  of  P.aeruginosa  as 
potential drug targets [10]. Here we compared these 
361  enzymes  (50  enzymes  in  unique  pathways  and 
311 enzymes in shared pathways) to that of the choke 
point  enzymes  obtained  in  the  above  metabolic 
network tool analysis. This approach resulted in 227 
targets  matching  with  the  previously  reported  361 
targets  of  which  25  targets  belong  to  the  unique 
pathways of the pathogen. The remaining 202 targets 
matched  with  that  of  the  enzymes  in  the  shared 
pathways between the pathogen and human. A total of 
63%  of  proposed  drug  targets  are  choke  point 
reactions in the P.aeruginosa genome. We identified 
top  10  choke  point  enzymes in P.aeruginosa using 
the pathway hunter tool. These enzymes were ranked 
based on the number of shortest paths (Table 3). 
 Enzyme 
Id 
Enzyme Name 
 
Gene Ids 
 
Load 
value 
(in)   
Load 
value 
(out)   
k-Sho rtest 
paths 
(in)   
k-Shortest 
paths 
(out)   
Hum an 
choke 
point   
Top BLA ST 
hit (identity) 
(% )   
2.4.2.7*  Adenine phosphoribosy l transferase  PA1543  1.11  1.89  74459  74459  No  No Homologue 
2.4.2.8 
 
Hypoxanthine phosphoribosyl 
transferase 
PA4645 
 
0.85 
 
1.52 
 
60639 
 
60639 
 
Yes  26% 
2.7.4.6 
 
Nucleoside-diphosphate kinase   PA3807 
 
1.47 
 
1.17 
 
55297 
 
55297 
 
Yes  48% 
2.7.4.14  Cy tidylate kinase  PA3163 
 
1.37 
 
1.59 
 
50169 
 
50169 
 
No  No Homologue 
6.2.1.1*  Acetate-CoA ligase  PA0887 
PA1997 
PA2555 
PA4733 
-0.03  -0.16  48355  48355  No  No Homologue 
2.6.1.1  Aspartate transaminase  PA2828 
PA3798 
PA4722 
PA4976 
0.54  0.34  40463  40463  Yes  33% 
2.2.1.1  Transketolase  PA0548  1.36  1.46  40019  40019  Yes  26% 
4.2.1.11  Phosphopyruvate hy dratase  PA3635  2.28  2.07  38260  38260  Yes  54% 
3.6.1.7*  Acy lphosphatase  PA0954  4.07  1.87  28547  28547  No  No Homologue 
6.3.5.4*  Asparagine synthase 
(glutamine-hydrolysing) 
PA0051 
PA2084 
PA3459 
0.03  -0.05  25142  25142  No  No Homologue 
   
Table  3.  Top  10  Choke  point  enzymes  in  P. 
aeruginosa  ranked  by  number  of  shortest  paths.   
* Choke point enzymes reported as potential drug 
targets in the common pathways shared between 
the pathogen and human. 
Our approach identified top 10 choke point enzymes 
of which 4 of them were already reported as potential 
drug  targets  in  our  previous  work.  An  additional 
criterion for being a chokepoint enzyme is that it must 
not have isozymes which would make it more likely 
to be a potential drug target. Comparing the choke 
point enzymes with the human genome sequence will 
help in differentiating pathogen choke points and the 
human choke point enzymes. 
The  top  10  choke  point  enzymes  were  BLASTp 
searched against human protein sequence database at 
an  E-value  cutoff  of  10
-2.  Five  out of ten enzymes 
were identified as choke points only in pathogen and 
not in human. The enzymes adenine phosphoribosyl 
transferase  (EC  2.4.2.7),  cytidylate  kinase  (EC 
2.7.4.14),  acetate-coA  ligase  (EC  6.2.1.1), 
Acylphosphatase  (EC  3.6.1.7)  and  asparagine 
synthase  (EC  6.3.5.4)  do  not  share  any  significant 
homology  with  the  human  genome  (Table  3).  
Therefore  targeting  these  enzymes  might  cause  the 
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lethality  of  the  pathogen.  Adenine   
phosphoribosyltransferases  catalyze  the  Mg2
+ 
dependent reaction that transforms a purine base into 
its corresponding nucleotide and they are present in a 
wide variety of organisms. They play major roles in 
purine salvage among most living organisms.  Most 
of them rely on multiple purine salvage pathways to 
replenish  their  purine  nucleotides.  A  simultaneous 
inhibition  of  all  the  major  purine  salvage  enzymes 
will  be  necessary  for  depleting  purine  nucleotides 
from these pathogenic organisms.  
ATP  or  GTP  formation  by  substrate  level 
phosphorylation of ADP or GDP at the expense of the 
free  energy  of  the  thioester  bond  of  acyl-CoA  is  a 
well known and much studied biochemical process. 
Enzymes (acetate-coA ligase) catalyzing this process 
play  central  roles  in  energy  metabolism.  Potential 
drug targets should adversely affect the pathogen but 
not the host human and therefore if the drug target has 
a  homologous  enzyme  in  human  it  should  not  be 
essential. 
4. CONCLUSION 
It must be noted that chokepoints may not be essential 
if  they  create  unique  intermediates  to  an  essential 
product  and  exhibit  alternate  pathway  reactions. 
Alternatively, a model might overestimate the number 
of redundant reactions or pathways; this can be due to 
errors  in  annotation  and  unaccounted  regulation. 
Equally true, each component of the reaction network 
may  be  present  in  the  target  organism  but  not 
expressed under the conditions to be examined. The 
above  discussed  computational  approaches  herein 
yield a larger pool of candidates which are not biased, 
thereby providing a wider range of new potential drug 
targets. 
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